Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Taprizosin

Copy Product Info
🥰Excellent
Catalog No. T28922Cas No. 210538-44-6
Alias UK-338003, UK338003, UK-338,003, UK 338003, Taprizosin Mesylate

Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.

Taprizosin

Taprizosin

Copy Product Info
🥰Excellent
Purity: 99.11%
Catalog No. T28922Alias UK-338003, UK338003, UK-338,003, UK 338003, Taprizosin MesylateCas No. 210538-44-6
Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$373In StockIn Stock
5 mg$896In StockIn Stock
10 mg$1,230In StockIn Stock
25 mg$1,880In StockIn Stock
50 mg$2,580In StockIn Stock
100 mg$3,400In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.11%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Taprizosin AI Summary
Taprizosin is a molecule with moderate lipophilicity (LogD = 3.0) and a pKa of 6.7. It exhibits metabolic stability in both human and Beagle dog liver microsomes, presenting different half-lives and intrinsic clearance rates. The compound shows varying bioavailability and absorption rates depending on the animal model, such as Beagle dogs and Sprague-Dawley rats, and the route of administration, whether oral or intravenous. Additionally, it has significant protein binding in the plasma of Beagle dogs, Sprague-Dawley rats, and humans..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.
SynonymsUK-338003, UK338003, UK-338,003, UK 338003, Taprizosin Mesylate
Chemical Properties
Molecular Weight506.58
FormulaC25H26N6O4S
Cas No.210538-44-6
SmilesNC=1C=2C(=C(OC)C(OC)=CC2N=C(N1)N3CC=4C(CC3)=C(NS(C)(=O)=O)C=CC4)C5=CC=CC=N5
Relative Density.1.401g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 60 mg/mL (118.44 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9740 mL9.8701 mL19.7402 mL98.7011 mL
5 mM0.3948 mL1.9740 mL3.9480 mL19.7402 mL
10 mM0.1974 mL0.9870 mL1.9740 mL9.8701 mL
20 mM0.0987 mL0.4935 mL0.9870 mL4.9351 mL
50 mM0.0395 mL0.1974 mL0.3948 mL1.9740 mL
100 mM0.0197 mL0.0987 mL0.1974 mL0.9870 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Taprizosin | purchase Taprizosin | Taprizosin cost | order Taprizosin | Taprizosin chemical structure | Taprizosin formula | Taprizosin molecular weight